Found 0 matching trials
Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod
PHASE3This study evaluated disease control during different lengths of treatment ...
Location
Novartis Investigative Site
Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
PHASE1Intracerebral hemorrhage (ICH) is a critical disease of public health impor...
Location
Multiple Locations
Safety and Efficacy of Fingolimod in MS Patients in China
PHASE3To evaluate the safety and efficacy of fingolimod 0.5mg vs. placebo in MS p...
Location
Multiple Locations
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
PHASE4A study of immune phenotype biomarkers in patients with Relapsing Multiple ...
Location
Novartis Investigative Site
Fingolimod in Schizophrenia Patients
PHASE2This will be a single site safety and proof of concept study conducted at t...
Location
Center for NeuroImaging
Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya
PHASE4A trial in patients with relapsing remitting multiple sclerosis (RRMS)
Mai...
Location
Universitaetsklinikum Muenster, Department of Neurology
Disease Control in RRMS Transferring Treatment From Natalizumab to Fingolimod
N/AThis is an observational study to develop new hypothesis regarding the dyna...
Location
University Hospital Basel, Switzerland